SLDB Alexander Cumbo sells $45K worth of shares
Feb 19, 2025, 5:33 AM
-9.41%
What does SLDB do
Solid Biosciences, headquartered in Charlestown, Massachusetts, develops gene therapies for Duchenne muscular dystrophy and other cardiac diseases, employing 88 staff since its IPO on January 26, 2018. Their pipeline includes multiple gene therapy candidates and novel platform technologies.
Alexander Cumbo sold 11,365 shares of SLDB on 14 February at $3.96 per share, worth a total of $45K. They now own 60,717 SLDB shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.